Navigation Links
Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
Date:9/25/2007

LONDON, Sept. 25 /PRNewswire/ -- Morria Biopharmaceuticals Plc, a private biopharmaceutical company focusing on first-in-class, novel non-steroidal anti-inflammatory drugs, today announced it has appointed Dr. Johnson Lau and Dr. David Sidransky to its board of directors.

Dr. Johnson Lau (MBBS, MD, FRCP) brings a wealth of experience from the medical, pharmaceutical and corporate fields, having a distinguished background in both academic medicine and executive-level management of pharmaceutical and biotechnology companies. Dr. Lau previously served Schering-Plough, ICN Pharmaceuticals and its subsidiary Ribapharm, and is currently a senior advisor to Novartis. He was formerly a managing director of healthcare investment banking of Roth Capital Partners. Dr. Lau also serves as a member of the board of directors of Chelsea Therapeutics, VioQuest Pharmaceuticals, XenoBiotic Laboratories and Kinex Pharmaceuticals. Dr. Lau is a Fellow of the Royal College of Physicians of the United Kingdom. He received both his medical degree and doctoral degree from the University of Hong Kong.

Dr. David Sidransky (MD) is the director of the Head and Neck Cancer Research Division at Johns Hopkins University School of Medicine and is also a professor of oncology, otolaryngology-head and neck surgery, cellular and molecular medicine, urology, and genetics and pathology at the university. He is currently vice-chairman of the board of directors of ImClone Systems, lead independent chairman at Alfacell Inc. and serves on the board of directors of Zila Inc. and Xenomics. Dr. Sidransky is a founder of several private biotechnology companies and has served on numerous scientific advisory boards of both private and public companies, including Medimmune, Telik, Roche and Amgen. He was formerly on the board of scientific counselors at the National Institute of Dental and Craniofacial Research and is a member of the Recombinant DNA advisory committee at the National Institutes o
'/>"/>

SOURCE Morria Biopharmaceuticals Plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009).... 2 Peregrine Pharmaceut...tion of patient enrollment in a dose confirmation ...th relapsed glioblastoma multiforme (GBM), the dea... monoclonal antibody linked to a radioisotope bein... Cotara specifically targets cells at the center o...
(Date:12/2/2009)...Israel, December 2 Gamida Cell ann...eclinical (animal study) safety and,efficacy of a ...m Weill,Cornell Medical College and Gamida Cell. T...nemias such as Cooley,s Anemia. , Gamida ...and, ex vivo,populations of stem/progenitor cells...
(Date:12/2/2009)...2 /PRNewswire-Asia/ -- The world is going through,...certainty is part of many,businesses and industrie...relatively immune to the economic downturn, becaus...ng the midst of the difficult times this year, the...rated an R&D center in Shanghai, the largest o...
(Date:12/1/2009)... Reportlinker.com announces that a...talogue: ,, Chromium - Global Market Trends ...ium---Global-Market-Trends.html ,, Worldwide d...nless steel, while growth in aerospace and industr...th of chromium metal. Environmental constraints an...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...ly Significant Improvements in Function and Tissue...pinal Cord Injury Model, SAN DIEGO, Nov. 7 Sanga...day the presentation of preclinical data from,its ...at Neuroscience 2007,the 37th Annual Meeting of th...icant effect on both recovery of hind-limb functio...
...., Nov. 7 SyntheMed, Inc. (OTC,Bulletin Board: SY...ment,and commercialization of anti-adhesion, tissu...ay that it has filed a universal shelf registratio...ssion (SEC) that, if,declared effective by the SEC... up to $20 million of its common stock, debt secur...
...lif., Nov. 7 ARYx Therapeutics,Inc. announced tod...of,5,000,000 shares of its common stock at a price... by ARYx Therapeutics. In addition, ARYx,Therapeut...o purchase up to,an additional 750,000 shares to c...mmon stock will trade on the NASDAQ Global Market ...
Other Biology Technology:Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting 2Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting 3Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting 4Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting 5SyntheMed Files Universal Shelf Registration 2ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering 2
(Date:12/1/2009)...chnology has been awarded a U.S. Air Force Center ...harvesting and adaptive materials, and to develop ...the modern warfighter. , The $10.5 million Cent...c Nanostructures and Improved Cognition (BIONIC) c...h Sandhage, professors in Georgia Tech,s School of...
(Date:12/1/2009)...n attacks by sharks can be solved with a new techn...omp they put on their victims, according to a Univ... In a method analogous to analyzing human fingerpr...sely comparing shark bites to the jaws and teeth o...ector of the International Shark Attack File, whic...
(Date:12/1/2009)...apsed video of individual breast tissue cells reve...l: a protein that cycles between two major compart...more complete view of the internal signals that ca...ry in cancer and are targets of drug development. ... growth factors, travels back and forth between th...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Elsevier Joins InChI Trust as a Charter Member 13963 1Elsevier Joins InChI Trust as a Charter Member 13963 2Elsevier Joins InChI Trust as a Charter Member 13963 3Elsevier Joins InChI Trust as a Charter Member 13963 4Philadelphia Attorney Carol Nelson Shepherd Presents at the 2009 Pennsylvania Association for Justice Master Series 56718 1Philadelphia Attorney Carol Nelson Shepherd Presents at the 2009 Pennsylvania Association for Justice Master Series 56718 2National Geographic and HBO Among Those Honored in 1st Annual International Scientific Animation Awards and Forum 56713 1National Geographic and HBO Among Those Honored in 1st Annual International Scientific Animation Awards and Forum 56713 2National Geographic and HBO Among Those Honored in 1st Annual International Scientific Animation Awards and Forum 56713 3
...University of Arizona-led international team of sc...ant to answer the question, What is the future of ...the next generation of culturally experienced scie...ration with interdisciplinary training in earth sy...National Science Foundation-funded project is call...
... YORK, NY The Lupus Research Institute (LRI) stra...temic lupus, the autoimmune disease, has now yield...ding from the National Institutes of Health and ot... progress report has determined. , To date, 36 ...nts from the 7-year-old LRIan Institute investment...
...increase depth and breadth of coverage, applicabil...iates, the Global Biodiversity Information Facilit...00,000,000) high quality data records available vi... holders of such data around the world to prioriti... broaden biodiversity data coverage of the whole g...
Other Biology News:Univ. of Arizona receives $2.5 million to study Amazon forests and climate change 2Univ. of Arizona receives $2.5 million to study Amazon forests and climate change 3Lupus Research Institute strategy delivers $30 million in national funding 2GBIF sets goal of mobilizing 1 billion records by end of 2008 2
... can be used in intracellular staining of post-tra...bilize cells and to serve as an antibody diluent a... permeabilization is a reversible process, it is i...nin during intracellular staining. Applications: ...
Mouse Anti-Human PREB Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
...mixer R offers maximum application versatility for..., and cooling. Its active heating/cooling function...ure control ranges. Five different thermoblocks, w... available for: 0.5 ml, 1.5 ml, and 2.0 ml volumes...
Biology Products: